Member Info for MrJinx

He’s posted four times on this board and his previous posts on the 8th September stated the same thing. Whether there was a halt or not, it’s apparent he only wants to post to create indecision and confusion.

Ooh, another warrior that doesn’t like his fibs being found out :0D

Rubbish. I’ve just been quoted to buy. Fool.

DCNY Summit speaker list is very Venture Capitalist heavy. JP Morgan, Morgan Stanley and HSBC also representing.

Managed to get my four x 500 top-ups, in the end under £8. Last for me now.

10% spread and NT to buy £5k

Good grief, everyone chill out. RMc is an internet troll, a wind up merchant (WUM). Leave him to his internet porn in his mummy’s spare room.

I don’t think we’ll get an RNS after 28 days of P3 treatment. If you look at the first two, the safety profile RNS’ were released on calendar month anniversaries. So we should get it on the 15th September. All things being equal, and all that…

Hahaha what, higher than 2.5p in old money???

You’ve answered your own question Aldeboring. The drug you name has an OS time 9.3m WITH toxicity and side effects. You don’t mention when the patients relapsed or indeed if there was ever a recorded remission or just stability of disease. With toxicity and side effects, you then need to factor in quality of life in that 9 months, as they wouldn’t have just died. So how long did they suffer and how much time was spent out of a care facility?

HG-CT1, as far as we know so far, has no toxicity and the trial patients have responded positively to treatment.

So rather than throwing some sort of conundrum into the mix, you actually highlighted why HG-CT 1 is so desperately needed.

It’s roughly 5p/£20 inc all dilutions from a high of 7p ‘ish. Just over a third to nearly a 50% increase in shares. But then that is just on FDA approval, not P3 all nice and snuggly at home, and receiving a bucketload of hope for their future life. Surely that’s worth at least double the high of pre-trials?!?!?

MrIndia and his b/s conspiracy hysteria again. Just enjoy the ride, yer melt.

£9.30-9.80…that rocket is ready to blow

£9-9.30

Vlad couldn’t make it any more clear without a separate RNS “…early clinical data supporting growing confidence in both safety and potential efficacy.”

£1bn divided by 8m shares’ish = £125…or 31p in old money.

Just thinking out loud.

I’m guessing ‘yes’ as the spread has just widened.

Is the 20,000 share sale still at £8?

keep your political opinions to yourself tilly, yer gob****e!!

i don’t know why you’re mocking moorscloud. my nephew died from aml 18 months after diagnosis and this was explained to him. so **** you!